Private Equity

Updated:

New Hill Management

New Hill Management is a Boston-based private equity firm focused on early-stage venture investing and corporate spin-offs. The firm operates at the...

New Hill Management logo

New Hill Management

New Hill Management is a Boston-based private equity firm focused on early-stage venture investing and corporate spin-offs. The firm operates at the intersection of academic research, corporate R&D, and startup formation — a structural niche common to funds anchored in the Boston-Cambridge innovation corridor. Its mandate covers seed-stage startups and direct equity stakes in technology ventures spun out of larger organizations. The firm deploys capital across early-stage venture, startup seed rounds, and corporate spin-off transactions. Asset classes in scope include direct private equity, venture capital, and structured spin-off vehicles. Geographic focus centers on the Northeastern United States, with Boston and Cambridge's university and biotech clusters serving as primary origination pools. The firm seeks out technology ventures where intellectual property or team talent originates inside a parent entity before establishing independent commercial operations. Team size and assets under management are not publicly disclosed. The firm maintains a single office in Boston. No affiliated philanthropic foundations, co-investment clubs, or parallel vehicles are publicly known. In the absence of owned website content or LinkedIn presence, operational details remain limited to what is observable through regulatory filings and directory listings. New Hill Management's structural differentiator lies in its explicit spin-off focus — a sourcing model that positions the firm between corporate venture arms and traditional seed funds. Rather than competing for standard accelerator graduates, the firm appears built to capture deal flow originating inside corporate and university labs that might otherwise remain captive or under-commercialized.

General information

Firm type

Private Equity

Year founded

2001

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Boston

Corporate office

Boston, MA, United States

Frequently asked questions

What investment stages does New Hill Management target?

New Hill Management targets early-stage ventures, including seed rounds and startup formations. Its strategy also explicitly covers spin-offs — companies carved out of existing corporate or university R&D environments. This dual focus places the firm at the very earliest point of company formation, before traditional growth-equity or buyout managers typically engage.

How does New Hill Management source deal flow?

The firm's spin-off mandate suggests origination is tied to corporate divestiture activity and university technology-transfer offices. By focusing on ventures emerging from established R&D pipelines, New Hill Management likely sources through direct relationships with corporate development teams, academic tech-licensing officers, and founder teams seeking independence. This differs from standard venture deal flow sourced through accelerators or broker networks.

Is New Hill Management a single-family office or a traditional fund manager?

Public records classify New Hill Management as a private equity asset manager, not a family office. The firm's structure, leadership, and capital base are not publicly disclosed, and no family wealth origin has been identified. Allocators should treat it as an independent fund manager absent evidence of a single-family anchor.

Does New Hill Management make fund commitments or only direct investments?

Based on its stated strategy of early-stage venture, spin-offs, and direct venture capital, New Hill Management appears to make direct equity investments in portfolio companies rather than acting as a fund-of-funds. Available records do not indicate an LP commitment program, though the firm's full mandate is not publicly detailed.

What is the geographic focus of New Hill Management?

The firm is headquartered in Boston, Massachusetts, and its early-stage and spin-off focus aligns with the Boston-Cambridge innovation corridor. While no explicit geographic restrictions are publicly stated, the firm's single-office posture and proximity to MIT, Harvard, and the Route 128 biotech cluster suggest a Northeast-heavy portfolio.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Boston Private Equity profiles